Basic Information
LncRNA/CircRNA Name | TFAP2A-AS1 |
Synonyms | NA |
Region | GRCh38_6:10409340-10416446 |
Ensemble | ENSG00000229950 |
Refseq | NR_033910 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay |
Sample | BC tissues ,cell lines(MCF-10A,MCF-7, MDA-MB-231, MDA-MB-435, T47D, SKBR-3 ) |
Expression Pattern | up-regulated |
Function Description | Real-time PCR (qRT-PCR) assay was performed to detect the relative mRNA expression of TFAP2A-AS1 and miR-933. Flow cytometry analysis, CCK-8 assay, and Transwell assay were applied to detect the effects of TFAP2A-AS1 overexpression on cell cycle, apoptosis, viability, and invasion of BC cells. |
Pubmed ID | 30768589 |
Year | 2019 |
Title | Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2. |
External Links
Links for TFAP2A-AS1 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |